Greater Boston
Commercial leader with more than 15 years of pharmaceutical industry experience spanning across global, regional and country level - primarily within Oncology across diverse geographies including in-depth regional exposure to emerging markets (Asia, Latin America, Middle East). Demonstrated strong competency in global, regional and local marketing strategy and operation roles; including P&L responsibilities, commercial excellence, product launches, direct team leadership and matrix organization, business development, portfolio planning & omnichannel strategy. Unrestricted mobility, high learning agility and willing to take up new challenges.
Global commercial lead for 2 oncology brands: Alunbrig (Lung Cancer) and Ninlaro (Multiple Myeloma). Driving global brand strategy in collaboration with cross-functional GBT members and regional representatives (US, EUCAN, JP and RoW). Expanded role coverage to support US marketing for Ninlaro.
As global business lead for Hematology Integrated Disease Area Strategy (iDAS), my key focus is to establish collaboration across the global organization (OBU, OTAU, ODDU) and play a critical role in identifying business development opportunities, creating disease area strategies, and providing business input into global program teams (GPT) for pipeline assets. New product planning lead for multiple oncology pipeline assets (hematology & solid tumors) across different phases of development (from pre-IND to phase 3) and diverse modalities - identifying white space opportunities, target product profile (TPP) and business case to support each inflection points throughout the clinical development plan. Pioneering a potentially-transformative digital tool with support of Digital, Data & Technology and Advanced Analytics team to manage TPP within the organization.
Global new product planning lead (hematology and solid tumors) for early to mid-stage oncology pipeline assets and interim BD S&E commercial lead (Feb-Aug 2024) based in Cambridge, MA, USA. Key member & business representative in GPT (global product team). Leader of the business sub-team consisting of various cross-functional stakeholders. Project co-lead for a pilot digital solution in improving efficiencies in managing TPP (target product profile).
2016-2018: Head of sales & marketing with 7 direct reports, core responsibilities include managing P&L of Solid Tumor portfolio (8 brands - Breast, Lung, RCC, Melanoma, and other rare indications), strategic brand management, business development opportunities, commercial excellence, product launches, product lifecycle management, sales coaching and talent development. 2015-2016: Product management - therapeutic areas including Lung, RCC, Sarcoma & Melanoma. Instrumental in successfully launching 3 products in a year.
Marketing initiatives, above-country marketing tactics coordination, strategic business development including portfolio integration and brand management for Novartis Oncology portfolio (solid tumor and haematology) for Asia Pacific - South Africa (13 countries)
Specialty Products - Nephrology (1 year) Haematology (2 years) - therapeutic areas include Chronic Myeloid Leukemia & Myelofibrosis.
Regulatory Affairs for pharmaceuticals and medical devices. Business Development & Product Management for renal drugs portfolio.